TNFRSF8 and mature T-cell and NK-cell non-Hodgkin lymphoma: In fact, in line with the varying and inconsistent expression of the CD30 molecule in PTCL_NOS cells, data from the ECHELON-2 trial cannot be extrapolated and generalized to all PTCL subtypes without the risk of important interpretation biases.